Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2018 (2018), Article ID 3973250, 9 pages
https://doi.org/10.1155/2018/3973250
Research Article

The Abnormal Expression of MicroRNA-542-3p in Hepatocellular Carcinoma and Its Clinical Significance

1Department of Hepatobiliary and Pancreatic Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China
2Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China

Correspondence should be addressed to Yufeng Yuan; nc.ude.uhw@1791fynauy

Received 4 July 2017; Revised 30 October 2017; Accepted 15 November 2017; Published 11 February 2018

Academic Editor: Marco E. M. Peluso

Copyright © 2018 Xi Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. L. Siegel, K. D. Miller, and A. Jemal, “Cancer statistics, 2016,” CA: A Cancer Journal for Clinicians, vol. 66, no. 1, pp. 7–30, 2016. View at Publisher · View at Google Scholar · View at Scopus
  2. G. Mazzoccoli, R. Tarquini, A. Valoriani, J. Oben, M. Vinciguerra, and F. Marra, “Management strategies for hepatocellular carcinoma: old certainties and new realities,” Clinical and Experimental Medicine, vol. 16, no. 3, pp. 243–256, 2016. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Faivre, M. Bouattour, and E. Raymond, “Novel molecular therapies in hepatocellular carcinoma,” Liver International, vol. 31, Supplement 1, pp. 151–160, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. M. F. Yuen, J. L. Hou, A. Chutaputti, and Asia Pacific Working Party on Prevention of Hepatocellular Carcinoma, “Hepatocellular carcinoma in the Asia pacific region,” Journal of Gastroenterology and Hepatology, vol. 24, no. 3, pp. 346–353, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. D. P. Bartel, “MicroRNAs: genomics, biogenesis, mechanism, and function,” Cell, vol. 116, no. 2, pp. 281–297, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Winter, S. Jung, S. Keller, R. I. Gregory, and S. Diederichs, “Many roads to maturity: microRNA biogenesis pathways and their regulation,” Nature Cell Biology, vol. 11, no. 3, pp. 228–234, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Lu, G. Getz, E. A. Miska et al., “MicroRNA expression profiles classify human cancers,” Nature, vol. 435, no. 7043, pp. 834–838, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Baranwal and S. K. Alahari, “miRNA control of tumor cell invasion and metastasis,” International Journal of Cancer, vol. 126, no. 6, pp. 1283–1290, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Schickel, B. Boyerinas, S. M. Park, and M. E. Peter, “MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death,” Oncogene, vol. 27, no. 45, pp. 5959–5974, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. L. Tutar, E. Tutar, and Y. Tutar, “MicroRNAs and cancer; an overview,” Current Pharmaceutical Biotechnology, vol. 15, no. 5, pp. 430–437, 2014. View at Publisher · View at Google Scholar
  11. S. Lin and R. I. Gregory, “MicroRNA biogenesis pathways in cancer,” Nature Reviews Cancer, vol. 15, no. 6, pp. 321–333, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. N. Yanaihara, N. Caplen, E. Bowman et al., “Unique microRNA molecular profiles in lung cancer diagnosis and prognosis,” Cancer Cell, vol. 9, no. 3, pp. 189–198, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. L. F. Sempere, M. Christensen, A. Silahtaroglu et al., “Altered MicroRNA expression confined to specific epithelial cell subpopulations in breast cancer,” Cancer Research, vol. 67, no. 24, pp. 11612–11620, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. C. N. Hayes and K. Chayama, “MicroRNAs as biomarkers for liver disease and hepatocellular carcinoma,” International Journal of Molecular Sciences, vol. 17, no. 3, p. 280, 2016. View at Publisher · View at Google Scholar · View at Scopus
  15. I. G. Papaconstantinou, A. Manta, M. Gazouli et al., “Expression of microRNAs in patients with pancreatic cancer and its prognostic significance,” Pancreas, vol. 42, no. 1, pp. 67–71, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Hayes, P. P. Peruzzi, and S. Lawler, “MicroRNAs in cancer: biomarkers, functions and therapy,” Trends in Molecular Medicine, vol. 20, no. 8, pp. 460–469, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Zhang, S. Wang, F. Han et al., “MicroRNA-542-3p suppresses cellular proliferation of bladder cancer cells through post-transcriptionally regulating survivin,” Gene, vol. 579, no. 2, pp. 146–152, 2016. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Cai, J. J. Zhao, N. Zhang et al., “MicroRNA-542-3p suppresses tumor cell invasion via targeting AKT pathway in human astrocytoma,” The Journal of Biological Chemistry, vol. 290, no. 41, pp. 24678–24688, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. X. Shen, Y. Si, Z. Yang, Q. Wang, J. Yuan, and X. Zhang, “MicroRNA-542-3p suppresses cell growth of gastric cancer cells via targeting oncogene astrocyte-elevated gene-1,” Medical Oncology, vol. 32, no. 1, p. 361, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. H. X. Wu, G. M. Wang, X. Lu, and L. Zhang, “miR-542-3p targets sphingosine-1-phosphate receptor 1 and regulates cell proliferation and invasion of breast cancer cells,” European Review for Medical and Pharmacological Sciences, vol. 21, no. 1, pp. 108–114, 2017. View at Google Scholar
  21. W. Wu, S. Dang, Q. Feng, J. Liang, Y. Wang, and N. Fan, “MicroRNA-542-3p inhibits the growth of hepatocellular carcinoma cells by targeting FZD7/Wnt signaling pathway,” Biochemical and Biophysical Research Communications, vol. 482, no. 1, pp. 100–105, 2017. View at Publisher · View at Google Scholar · View at Scopus
  22. G. A. Calin, C. D. Dumitru, M. Shimizu et al., “Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 24, pp. 15524–15529, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. C. M. Croce, “Causes and consequences of microRNA dysregulation in cancer,” Nature Reviews Genetics, vol. 10, no. 10, pp. 704–714, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. M. N. Poy, L. Eliasson, J. Krutzfeldt et al., “A pancreatic islet-specific microRNA regulates insulin secretion,” Nature, vol. 432, no. 7014, pp. 226–230, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. Z. Liang, Y. Li, K. Huang, N. Wagar, and H. Shim, “Regulation of miR-19 to breast cancer chemoresistance through targeting PTEN,” Pharmaceutical Research, vol. 28, no. 12, pp. 3091–3100, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. G. H. Shi, D. W. Ye, X. D. Yao et al., “Involvement of microRNA-21 in mediating chemo-resistance to docetaxel in androgen-independent prostate cancer PC3 cells,” Acta Pharmacologica Sinica, vol. 31, no. 7, pp. 867–873, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Garofalo, G. Di Leva, G. Romano et al., “miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation,” Cancer Cell, vol. 16, no. 6, pp. 498–509, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. P. M. Voorhoeve, C. le Sage, M. Schrier et al., “A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors,” Cell, vol. 124, no. 6, pp. 1169–1181, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. S. M. Johnson, H. Grosshans, J. Shingara et al., “RAS is regulated by the let-7 microRNA family,” Cell, vol. 120, no. 5, pp. 635–647, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Negrini, L. Gramantieri, S. Sabbioni, and C. M. Croce, “microRNA involvement in hepatocellular carcinoma,” Anti-Cancer Agents in Medicinal Chemistry, vol. 11, no. 6, pp. 500–521, 2011. View at Publisher · View at Google Scholar